Håber Biologics
Håber Biologics provides development and manufacturing of complex biopharmaceuticals to improve global patient access. They use a modular, multi-product facility and AI-enabled data recording to ensure quality from lab to market. Key technologies include single-use bioreactors, aseptic fill and finish, and scalable production of monoclonal antibodies, vaccines, gene therapies, and cell therapies. Their CDMO model serves biopharma companies with globally compliant manufacturing and distribution capabilities, aiming for scale and reliable access to medicines.
Håber Biologics
Håber Biologics provides development and manufacturing of complex biopharmaceuticals to improve global patient access. They use a modular, multi-product facility and AI-enabled data recording to ensure quality from lab to market. Key technologies include single-use bioreactors, aseptic fill and finish, and scalable production of monoclonal antibodies, vaccines, gene therapies, and cell therapies. Their CDMO model serves biopharma companies with globally compliant manufacturing and distribution capabilities, aiming for scale and reliable access to medicines.